[email protected]
CAS 137868-52-1 UDP-ALPHA-D-GALACTOSE DISODIUM SALT molecular structure lightbox
CAS RN: 137868-52-1

UDP-ALPHA-D-GALACTOSE DISODIUM SALT

Product Availability

Choose a grade to view its available package options.

9 package records9 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250110 100mg In stock Shanghai, Tianjin, Chengdu Inquiry
Batchno.20250320 100mg In stock Shanghai, Shandong, Hebei Inquiry
Batchno.20250430 10mg In stock Shanghai Inquiry
Batchno.20250808 10mg In stock Shanghai, Shandong, Guangdong, Chongqing, Hebei Inquiry
Batchno.20250718 1g In stock Shanghai Inquiry
Batchno.20260109 250mg In stock Shanghai, Shenzhen, Tianjin, Chengdu Inquiry
Batchno.20260205 250mg In stock Shanghai Inquiry
Batchno.20260521 25mg In stock Shanghai Inquiry
Batchno.20250630 50mg In stock Shanghai, Hebei Inquiry
  • Product code: SSC-047525
GET A QUOTE
Historical Factory Record

Historical Supply Reference

This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.

  • Pack sizes on record: 0.1g, 0.25g, 1g
  • Available purity: ≥95%
  • Inventory rows with stock: 0
  • Bulk packaging: confirmed by inquiry
Request Bulk Quote

Reference Pack Sizes

Reference pack sizes are shown below. Final availability, packaging and delivery schedule are confirmed by inquiry.

Recorded sizes, purity and stock details for CAS 137868-52-1
Pack Size Recorded Purity Available Qty Ship From Inquiry
0.1g ≥95% 0 Out of Stock Shanghai Inquiry
0.25g ≥95% 0 Out of Stock Hong Kong Inquiry
1g ≥95% 0 Out of Stock Hong Kong Inquiry

137868-52-1 / disodium;[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] [(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate

Standard CAS: 137868-52-1 Multi CAS: No
Basic Information Computed Properties

Basic Information

CAS
137868-52-1
Multi CAS
No
Molecular Formula
C15H22N2Na2O17P2
Molecular Weight
610.270000
Exact Mass
610.018910
SMILES
C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)([O-])O[C@@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)O)O)O.[Na+].[Na+]
InChI
InChI=1S/C15H24N2O17P2.2Na/c18-3-5-8(20)10(22)12(24)14(32-5)33-36(28,29)34-35(26,27)30-4-6-9(21)11(23)13(31-6)17-2-1-7(19)16-15(17)25;;/h1-2,5-6,8-14,18,20-24H,3-4H2,(H,26,27)(H,28,29)(H,16,19,25);;/q;2*+1/p-2/t5-,6-,8+,9-,10+,11-,12-,13-,14-;;/m1../s1
InChIKey
PKJQEQVCYGYYMM-QKYKBPIOSA-L

Computed Properties

Structural Parameters

Heavy atom count
38
Aromatic heavy atom count
6
Fraction Csp3
0.73
Rotatable bonds
9
H-bond acceptors
18
H-bond donors
7
Molar refractivity
104.35
TPSA
302.65

LogP / Solubility

WLOGP
-12.05
MLOGP
-10.55
XLogP3
-12.05
Consensus LogP
-11.55
Log S (ESOL)
4.44
Class (ESOL)
Highly soluble
Log S (Ali)
4.14
Class (Ali)
Highly soluble
Log S (SILICOS-IT)
5.29
Class (SILICOS-IT)
Highly soluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-15

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
9.5

Customers Also Viewed

Get In Touch

Contact Us